Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K

Alexander E. Yueh(University of Wisconsin–Madison), Dustin A. Deming(University of Wisconsin–Madison)

PLoS ONE

February 10, 2016

10.1371/journal.pone.0148730

Cited by 22

Related Papers

ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

|Nature Reviews Clinical Oncology|2020|365

PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors

|Oncogenesis|2015|75

Abstract CT028: A first-in-human phase 1 study of LY3537982, a highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C-mutant advanced solid tumors

|Cancer Research|2023|37

mTOR Inhibition Elicits a Dramatic Response in PI3K-Dependent Colon Cancers

|PLoS ONE|2013|22

Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal Cancers

|Cancers|2024|14